Lois Ayash

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Karen H. Antman, Lois Ayash, Anthony Elias et al. · Journal of Clinical Oncology · 1992 · 374 citations

Medicine, Oncology, Pharmacotherapy +17

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

AD Elias, Lois Ayash, KC Anderson et al. · Blood · 1992 · 260 citations · Full text

Medicine, Hematology, Oncology +17

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

Voravit Ratanatharathorn, Lois Ayash, C. Reynolds et al. · Biology of Blood and Marrow Transplantation · 2003 · 199 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Lois Ayash, J E Wright, Olga Tretyakov et al. · Journal of Clinical Oncology · 1992 · 190 citations

Medicine, Pharmacokinetics, Pharmacology +15

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

Lois Ayash, Anthony Elias, Catherine Wheeler et al. · Journal of Clinical Oncology · 1994 · 143 citations

Medicine, Oncology, Pharmacology +16